Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China
· Delayed Price · Currency is CNY 1.730
+0.020 (1.17%)
Apr 29, 2026, 3:00 PM CST
Kangmei Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 23,924 | 26,413 | 32,441 | 25,787 | 30,501 | 42,839 | Upgrade
|
| Market Cap Growth | -18.98% | -18.58% | 25.81% | -15.46% | -28.80% | 221.38% | Upgrade
|
| Enterprise Value | 22,904 | 25,389 | 31,918 | 24,904 | 28,797 | 76,028 | Upgrade
|
| Last Close Price | 1.73 | 1.91 | 2.34 | 1.86 | 2.20 | 3.09 | Upgrade
|
| PE Ratio | 2316.42 | 2557.44 | 3783.85 | 251.53 | - | 5.41 | Upgrade
|
| Forward PE | - | 2.56 | 2.56 | 2.56 | 2.56 | 2.56 | Upgrade
|
| PS Ratio | 4.56 | 5.03 | 6.25 | 5.29 | 7.30 | 10.32 | Upgrade
|
| PB Ratio | 3.27 | 3.61 | 4.50 | 3.64 | 4.37 | 4.30 | Upgrade
|
| P/TBV Ratio | 3.50 | 3.86 | 4.87 | 4.00 | 4.83 | 4.64 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 1006.12 | Upgrade
|
| P/OCF Ratio | 214.86 | 237.22 | - | - | - | 199.99 | Upgrade
|
| PEG Ratio | - | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | Upgrade
|
| EV/Sales Ratio | 4.36 | 4.83 | 6.15 | 5.11 | 6.89 | 18.31 | Upgrade
|
| EV/EBITDA Ratio | 55.24 | 65.19 | - | 52.89 | - | - | Upgrade
|
| EV/EBIT Ratio | 205.08 | 227.33 | - | 138.67 | - | - | Upgrade
|
| EV/FCF Ratio | -216.66 | - | - | - | - | 1785.59 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.02 | 0.04 | 0.04 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.44 | 0.44 | - | 0.49 | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 4.82 | Upgrade
|
| Net Debt / Equity Ratio | -0.14 | -0.14 | -0.12 | -0.11 | -0.18 | -0.22 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.71 | -2.71 | 6.36 | -1.70 | 1.70 | 0.89 | Upgrade
|
| Net Debt / FCF Ratio | 9.99 | 9.99 | 1.71 | 1.92 | 1.56 | -51.99 | Upgrade
|
| Asset Turnover | 0.39 | 0.39 | 0.37 | 0.33 | 0.27 | 0.17 | Upgrade
|
| Inventory Turnover | 1.77 | 1.77 | 1.76 | 1.54 | 1.26 | 0.91 | Upgrade
|
| Quick Ratio | 0.78 | 0.78 | 0.74 | 0.69 | 0.82 | 1.00 | Upgrade
|
| Current Ratio | 1.26 | 1.26 | 1.17 | 1.12 | 1.36 | 1.68 | Upgrade
|
| Return on Equity (ROE) | 0.17% | 0.17% | 0.17% | 1.47% | -31.78% | - | Upgrade
|
| Return on Assets (ROA) | 0.52% | 0.52% | -1.84% | 0.76% | -4.17% | -7.71% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.52% | 0.51% | -2.28% | 2.80% | -15.42% | -31.95% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.40% | 1.40% | -5.20% | 2.20% | -10.70% | -27.40% | Upgrade
|
| Earnings Yield | 0.04% | 0.04% | 0.03% | 0.40% | -8.81% | 18.48% | Upgrade
|
| FCF Yield | -0.44% | -0.40% | -1.51% | -1.62% | -2.62% | 0.10% | Upgrade
|
| Payout Ratio | - | - | 8.75% | - | - | 0.17% | Upgrade
|
| Buyback Yield / Dilution | -3.25% | -3.25% | -39.38% | 27.54% | -1.85% | -0.55% | Upgrade
|
| Total Shareholder Return | -3.25% | -3.25% | -39.38% | 27.54% | -1.85% | -0.55% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.